Clinical Trials on Clinical Study in Japan

Total 26 results

AstraZeneca

Completed

Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

Bioequivalence Study

Japan
Nobelpharma

Completed

Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets

Bioequivalence Study

Japan
AstraZeneca

Completed

Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

Bioequivalence Study

Japan
AstraZeneca

Completed

Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

Pharmacodynamics Study

Japan
UCB Biopharma SRL

Completed

A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study Participants

Healthy Study Participants

Japan
Akira Horiuchi

Recruiting

Comparison of Vortic Catch V Basket Catheter and Ordinary Basket Catheter for the Removal of Bile Duct Stones

Randomized Study

Japan
UCB Biopharma SRL

Recruiting

A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Participants

Healthy Study Participants

Japan
Bayer

Completed

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Clinical Pharmacology

Japan
Takeda

Completed

TAK-114 Single- and Multiple-Dose Phase 1 Study

Clinical Pharmacology

Japan
Takeda

Completed

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

Clinical Pharmacology

Japan
Takeda

Completed

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

Clinical Pharmacology

Japan
Bayer
Janssen Research & Development, LLC

Completed

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects

Clinical Pharmacology

Japan
Bayer
Janssen Research & Development, LLC

Completed

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on the Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 15 mg in Japanese Healthy Male Adult Subjects

Clinical Pharmacology

Japan
Takeshi Morimoto

Recruiting

GOREISAN for Heart Failure (GOREISAN-HF) Trial (GOREISAN-HF)

Heart Failure | Edema | Clinical Trial | Traditional Japanese Medicine | Kampo Medicine

Japan
Osaka University

Completed

Predictors Of Successful Extubation in Critically Ill Patients: Multicentre Observational Study (POSE)

Intubation | Critical Care | Extubation | Mechanical Ventilation | Weaning | Liberation From Mechanical Ventilation

Japan
Tokyo Study Group

Completed

Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes

GAD Ab Positive Clinically Type 2 Diabetic Patients

Japan
Osaka University
Hospital Rebagliati

Unknown

Prone Positioning and Spontaneous Breathing (PROSE)

Critical Illness | ARDS

Japan
Osaka University

Unknown

The Impact of Higher Positive End Expiratory Pressure on Patient-Ventilator Asynchrony

Critical Illness

Japan
University Hospital, Geneva
European Society of Intensive Care Medicine; European Society for Clinical...

Completed

The ICALIC International Multicentric Study (ICALIC)

Critical Illness

Japan, Austria, Belgium, Israel, Sweden, Switzerland
Osaka University
Hospital Rebagliati

Completed

Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography

Critical Illness | ARDS

Japan
Okayama Research Investigator Organizing Network

Unknown

Intubation and Extubation Over 48 Hours Mechanical Ventilation (INDEX48)

Critical Illness | Pneumonia, Ventilator-Associated

Japan
Lisata Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)

Critical Limb Ischemia | Thromboangiitis Obliterans | Buerger Disease | Atherosclerosis Obliterans

Japan
Novartis Pharmaceuticals
University of Pennsylvania

Recruiting

CAR-T Long Term Follow Up (LTFU) Study (PAVO)

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

United States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
C. R. Bard
Bard Ltd

Completed

Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Critical Limb Ischemia

United States, Japan, Austria, Canada, Switzerland, Italy, Belgium, Germany
Clinical Evaluation Research Unit at Kingston General...

Completed

The Effect of Higher Protein Dosing in Critically Ill Patients (EFFORT)

Critical Illness | Malnutrition

United Kingdom, United States, Canada, Saudi Arabia, Malaysia, Argentina, Australia, Brazil, Greece, Hong Kong, India, Iran, Islamic Republic of, Japan, Mexico, Panama, Puerto Rico
Boston Scientific Corporation

Active, not recruiting

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia (SAVAL)

Critical Limb Ischemia

United States, France, Japan, Belgium, Netherlands

Clinical Trials on Clinical Study in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations